MedTrace Logo

ECGi of SyncAV With MultiPoint Pacing

NCT06444386 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2024-06-05

No results posted yet for this study

Summary

The objective of this clinical study was to evaluate the impact of Multipoint Pacing (MPP) and SyncAV programming on ventricular electrical activation time and activation sequence using noninvasive electrocardiographic imaging (ECGi) in patients receiving cardiac resynchronization therapy (CRT).

Conditions

  • Cardiac Resynchronization Therapy

Interventions

DEVICE

MPP + SyncAV

Cardiac resynchronization therapy (CRT) features of MultiPoint Pacing (MPP) and SyncAV (dynamic atrioventricular delay programming) enabled.

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-29
Primary Completion
2023-07-12
Completion
2024-04-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06444386 on ClinicalTrials.gov